These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29330396)

  • 21. Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.
    Gao L; Zhang C; Gao L; Liu Y; Su Y; Wang S; Li B; Yang T; Yuan Z; Zhang X
    J Hematol Oncol; 2015 Jul; 8():90. PubMed ID: 26208715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Huntley D; Giménez E; Pascual MJ; Remigia MJ; Amat P; Vázquez L; Hernández M; Hernández-Boluda JC; Gago B; Piñana JL; García M; Martínez A; Mateo E; Gozalbo-Rovira R; Albert E; Solano C; Navarro D
    Bone Marrow Transplant; 2020 Jul; 55(7):1347-1356. PubMed ID: 32205853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The impact of donor human leukocyte antigen-Bw4 allele on natural killer cell reconstitution and transplant-related mortality in haploidentical transplantation].
    Zhao M; Xu ZL; Yu XX; Ding YY; Chang YJ; Zhang XH; Liu KY; Huang XJ; Zhao XY
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):453-461. PubMed ID: 38964919
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of childhood leukemia with haploidentical hematopoietic stem cell transplantation using parent as donor: a single-center study of 111 case.
    Sun Y; Xiao J; Li ZH; Fan SF; Shen Y
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4379-84. PubMed ID: 26636526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation.
    Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Koc Y; Tischer J; Blaise D; Gülbas Z; Van Lint MT; Bruno B; Mohty M; Nagler A
    Am J Hematol; 2018 Feb; 93(2):246-253. PubMed ID: 29114918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
    Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.
    McCurdy SR; Zhang MJ; St Martin A; Al Malki MM; Bashey A; Gaballa S; Keesler DA; Hamadani M; Norkin M; Perales MA; Reshef R; Rocha V; Romee R; Solh M; Urbano-Ispizua A; Waller EK; Fuchs EJ; Eapen M
    Blood Adv; 2018 Feb; 2(3):299-307. PubMed ID: 29440002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.
    Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Schafhausen P; Jaburg N; Löliger C; Schäfer P; Hinke A; Zander AR
    Br J Haematol; 2001 Jun; 113(4):1060-71. PubMed ID: 11442503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cytomegalovirus immunodominant HLA-I donor-recipient matching on the incidence and features of virus DNAemia and virus-specific T-cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation.
    Huntley D; Giménez E; Vázquez L; Pascual MJ; Amat P; Remigia MJ; Hernández-Boluda JC; García M; Gago B; Torres I; de la Asunción CS; Hernani R; Pérez A; Albert E; Piñana JL; Solano C; Navarro D
    Transpl Infect Dis; 2023 Jun; 25(3):e14065. PubMed ID: 37120821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.
    Mariotti J; Raiola AM; Evangelista A; Carella AM; Martino M; Patriarca F; Risitano A; Bramanti S; Busca A; Giaccone L; Brunello L; Merla E; Savino L; Loteta B; Console G; Fanin R; Sperotto A; Marano L; Marotta S; Frieri C; Sica S; Chiusolo P; Harbi S; Furst S; Santoro A; Bacigalupo A; Blaise D; Angelucci E; Mavilio D; Castagna L; Bruno B
    Blood Adv; 2020 Aug; 4(16):3900-3912. PubMed ID: 32813875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.
    Mariotti J; Maura F; Spina F; Roncari L; Dodero A; Farina L; Montefusco V; Carniti C; Sarina B; Patriarca F; Rambaldi A; Onida F; Olivieri A; Zallio F; Corradini P
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):885-90. PubMed ID: 24583412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
    Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients.
    Perry DA; Hakki M
    Transpl Infect Dis; 2016 Oct; 18(5):809-814. PubMed ID: 27502917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
    Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting.
    Bondanza A; Ruggeri L; Noviello M; Eikema DJ; Bonini C; Chabannon C; van der Werf S; van Biezen A; de Wreede LC; Crucitti L; Vago L; Merluzzi M; Massei MS; Veelken H; Koc Y; Bader P; Gruhn B; Locatelli F; Ciceri F; Toubert A; Velardi A;
    Bone Marrow Transplant; 2019 Jun; 54(6):867-876. PubMed ID: 30531916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.